NSE · AARTISURF
Aarti Surfactants Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹256 Cr with net profit ₹4 Cr — a 1.66% net margin, versus 1.8% the period before.
Shareholding
As of 2026-06-30
- Promoter49.84%
- Public50.08%
- FII0.08%
35,149 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.82× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #82 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,66,203 Cr | 286.99 | 15.34 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,552 Cr | 298.65 | 26.06 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,434 Cr | 134.79 | 5.59 | 13.07% | 11.9% |
| Linde India Limited | ₹57,119 Cr | 737.61 | 13.39 | 12.48% | 0.18% |
| Gujarat Fluorochemicals Ltd. | ₹50,111 Cr | 459.86 | 6.42 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,596 Cr | 98.13 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,803 Cr | 182.32 | 9.75 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,633 Cr | 192.39 | 8.21 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,924 Cr | 104.33 | 3.93 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,733 Cr | 148.77 | 3.03 | 10.77% | 6.41% |
| Aarti Surfactants Limited(this company) | ₹332 Cr | 79.19 | 1.36 | 5.04% | 1.44% |
AI analysis
AI-generated · google/gemini-2.5-flashAarti Surfactants Limited is listed on the Indian markets with a market capitalization of Rs 332 Cr. The company reported revenue of Rs 662.56 Cr, growing by 26.8%. Its earnings per share (EPS) for the last fiscal year stood at Rs 14.57.
Positives
- +Revenue grew by 26.8% to Rs 662.56 Cr.
- +Promoter pledge is 0%, indicating no shares are encumbered.
- +Debt-to-equity ratio is 0.33, suggesting a manageable debt level.
Negatives
- −Return on equity (ROE) is 5.04%, which is relatively low.
- −Return on capital employed (ROCE) is 8.21%, which may indicate inefficient capital utilization.
- −Promoter holding decreased from 45.04% in Mar 2022 to 49.87% in Mar 2026, then declined to 49.87% in Mar 2026, showing fluctuations.
- −FII holding decreased significantly from 1.55% in Sep 2021 to 0.14% in Mar 2026.
Financial Performance
Aarti Surfactants Limited's revenue for the most recent fiscal year was Rs 662.56 Cr, representing a growth of 26.8%. The net profit for the annual period ending Mar 2025 was Rs 14.54 Cr. Quarterly revenue for Mar 2026 was Rs 256.28 Cr, with a net profit of Rs 4.19 Cr. For Dec 2025, revenue was Rs 207.79 Cr and net profit was Rs 3.66 Cr.
Profitability & Returns
The company's earnings per share (EPS) for the last fiscal year was Rs 14.57. The return on equity (ROE) was 5.04%, and the return on capital employed (ROCE) was 8.21%. The profit margin stood at 143.7%, and the company's P/E ratio is 26.89.
Balance Sheet
Aarti Surfactants Limited has a book value of Rs 289.13. The debt-to-equity ratio is 0.33, indicating a moderate level of debt relative to equity.
Ownership & Pledges
As of Mar 2026, promoter holding in Aarti Surfactants Limited was 49.87%, with public holding at 49.99%. Foreign Institutional Investors (FII) held 0.14%. Promoters have not pledged any shares (0% pledged).
Regulatory & Surveillance
The company is not currently under any surveillance measure, according to the provided data.
Data as of — price: 2026-07-29 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.